RavenQuest BioMed Inc.
RVVQF
$0.00
$0.000.00%
| 07/31/2019 | 04/30/2019 | 01/31/2019 | 10/31/2018 | 07/31/2018 | |
|---|---|---|---|---|---|
| Net Income | 3.67% | 10.78% | -197.17% | -665.92% | -737.16% |
| Total Depreciation and Amortization | 2,023.51% | 11,548.39% | 57,780.00% | 705,550.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.93% | 134.10% | 72.63% | 602.95% | 732.93% |
| Change in Net Operating Assets | 88.13% | 109.00% | 1,554.70% | 296.23% | -2,011.19% |
| Cash from Operations | 77.37% | 80.27% | 398.77% | 94.09% | -18,374.52% |
| Capital Expenditure | 88.15% | 55.10% | -455.36% | -320,162.50% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -283.74% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 88.15% | 92.16% | -102.38% | -2,300.32% | -- |
| Total Debt Issued | -- | -100.00% | -- | -40.21% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -65.98% | -- |
| Issuance of Common Stock | -69.70% | -76.37% | -- | -33.69% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -78.12% | 94.86% | -- | 88.59% | -- |
| Cash from Financing | -80.57% | -89.88% | -- | -43.43% | 1,000.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.02% | -89.43% | 144.29% | -135.52% | -679.31% |
